U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774312) titled 'STN-tTIS With Different Intervention Intervals Versus Standard Medical Treatment for Parkinson's Disease' on Aug. 17.
Brief Summary: The goal of this clinical trial is to compare the efficacy and safety of different Intervention Intervals of subthalamic nucleus-targeted transcranial temporal interference stimulation (STN-tTIS) in patients with Parkinson disease.
Previous studies suggest that STN-tTIS may improve motor symptoms in people with Parkinson disease. However, most previous studies evaluated only one stimulation session. It remains unclear how often STN-tTIS should be administered during a repeated treatment course and whe...